Arcellx

As a standalone entity before the acquisition, Arcellx reported approximately 520.1 million dollars in cash, cash equivalents and marketable securities at December 31, 2025 and guided that resources funded operations into 2028. No material debt was disclosed, but operating cash burn increased in 2025 as registrational activities and commercial readiness scaled.

Post‑acquisition, financial resilience is effectively that of Gilead/Kite, which eliminates near‑term financing risk for the programs.